HOME >> MEDICINE >> NEWS
Jefferson scientists help explain statins' effects in Alzheimer's disease

Scientists at Jefferson Medical College and the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia have taken another step in understanding the potential effects of anti-cholesterol drugs on Alzheimer's disease. They have identified a biochemical pathway that explains the activity of statins, particularly their ability to break down an early form of the protein amyloid that clusters and forms sticky plaques in the Alzheimer's brain.

The results may eventually help provide new targets for anti-amyloid drugs to help treat Alzheimer's disease. They report their findings Jan. 11, 2005 in the online journal the Public Library of Science Medicine.

Some epidemiological studies have found a link between people taking statin drugs to lower blood cholesterol and a lower incidence of Alzheimer's. Statins work by inhibiting an enzyme involved in cholesterol production, and currently is being tested in clinical trials for their possible effects in slowing the progression of Alzheimer's.

In a series of experiments, Sam Gandy, M.D., Ph.D., director of the Farber Institute for Neurosciences at Jefferson, Steve Pedrini, Ph.D., a postdoctoral fellow in Neurology in Jefferson Medical College of Thomas Jefferson University and in the Farber Institute for Neurosciences and their co-workers found evidence suggesting that an enzymatic pathway called Rho/ROCK may play an important role in the metabolism of APP (amyloid-beta peptide precursor protein), which is an early form of amyloid, and in turn, the ability of statins to break down a form of APP.

According to Dr. Gandy, APP can be broken down in two ways: "Bad cleavage" releases toxic amyloid-beta; "good cleavage" destroys it. Evidence shows that when the pathway ROCK1 is active, less good cleavage occurs. Statins, however, reduce ROCK1 activity, making it more likely that good cleavage will be in effect.

"It's particularly important to understand the pathways
'"/>


10-Jan-2005


Page: 1 2

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists find zinc may help prevent esophageal, oral cancers
5. Jefferson virologists coax HIV out of hiding
6. Jefferson scientists find way to see breast cancer activity from outside the body
7. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
8. Jefferson scientists use gene therapy to rescue failing hearts in animals
9. Jefferson scientists reveal how some types of rabies invade the brain
10. Jefferson neuroscientists studying new type of Alzheimers drug to halt disease progression
11. Jefferson scientists uncover new evidence to help explain statins effects in Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... Verdes, CA (PRWEB) , ... February 17, 2017 ... ... emotional flow is Dr. Carol Francis' goals for each and every ... Conference, Dr. Carol Francis will demonstrate five different brainwave tools which help energize ...
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one ... in the 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare ... is recognized across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... by fall 2017 season , Trinity Health and the U.S. Soccer Foundation announced ... Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring program, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica ... focusing on all facets of clinical trial planning and management. Pharmica discussed the ... and more. In addition, attendees stopping by Pharmica’s booth were able to demo ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As ... showcase its anatomic and molecular pathology workflow solution, as well as its new ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... SCOTTSDALE, Ariz. , Feb. 16, 2017 HealthInfoNet ... announced today it is partnering with Orion Health on the ... of all Maine residents, clinical information ... hospitals and over 500 ambulatory care sites. Pending ... deploy Orion Health,s Amadeus , a precision medicine platform ...
(Date:2/16/2017)...   Spectralink Corporation , the global leader ... manufacturing and hospitality industries, today announced the results ... support features of its PIVOT™:SC (8744) ... study, conducted by The Tolly Group, showed quantifiable ... with dedicated hardware scanners. Spectralink introduced ...
(Date:2/16/2017)... TEL AVIV, Israel , Feb. 16, 2017 ... company, today announced the appointment of Harvey ... and Chief Executive Officer of ARIAD Pharmaceuticals, Inc., ... of Medinol US Inc., effective immediately.  Dr. Berger, ... areas of business development, global strategy, new business ...
Breaking Medicine Technology:
Cached News: